MedPath

Effects of Shoes Insoles on Symptoms and Disease Progression in Knee Osteoarthritis

Not Applicable
Completed
Conditions
Osteoarthritis
Interventions
Device: Laterally wedged shoe insoles
Device: Control insole group
Registration Number
NCT00415259
Lead Sponsor
University of Melbourne
Brief Summary

It is hypothesised that laterally wedged insoles will result in reduced knee pain and cartilage volume loss after 12 months of wear, compared to control insoles. People with symptomatic knee osteoarthritis will be recruited from the community and randomised to wear either laterally wedged insoles or control insoles for 12 months. Patients will be assessed at baseline and at 12 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Eligibility will be confirmed by radiographic and clinical examination
  • People with medial tibiofemoral joint OA fulfilling American College of Rheumatology classification criteria and reporting average knee pain on walking >3 on an 11-point scale
  • varus knee malalignment on standing anteroposterior lower limb x-ray.
Exclusion Criteria
  • advanced radiographic knee OA (Kellgren and Lawrence stage 4
  • knee surgery or intra-articular corticosteroid injection within 6 months
  • current or past (within 4 weeks) oral corticosteroid use
  • systemic arthritic conditions
  • history of tibiofemoral/patellofemoral joint replacement or tibial osteotomy
  • any other muscular, joint or neurological condition affecting lower limb function
  • ankle/foot pathology or pain that precludes the use of insoles
  • use of foot orthotics within past 6 months and
  • use of footwear that does not accomodate an insole.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laterally wedged shoe insolesLaterally wedged shoe insolesFull-length 5 degree lateral wedged insoles worn inside the shoes daily for 12 months
Flat control insolesControl insole group-
Primary Outcome Measures
NameTimeMethod
Knee pain via a visual analogue scaleMeasured at baseline and 12 months
Disease progression via MRI measurements of knee cartilage volumeMeasured at baseline and 12 months
Secondary Outcome Measures
NameTimeMethod
Western Ontario and McMaster Universities (WOMAC) Oestoarthritis IndexMeasured at baseline and 12 months
Patient perceived response to treatmentMeasured at baseline and 12 months.
Health-related quality-of-life (via SF-36, AQoL questionnaires)Measured at baseline and 12 months
Recorded use of health careMeasured at baseline and 12 months

Trial Locations

Locations (1)

Centre for Health Exercise & Sports Medicine, School of Physiotherapy, The University of Melbourne

🇦🇺

Melbourne, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath